BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 21847071)

  • 1. Antiviral properties of lactoferrin--a natural immunity molecule.
    Berlutti F; Pantanella F; Natalizi T; Frioni A; Paesano R; Polimeni A; Valenti P
    Molecules; 2011 Aug; 16(8):6992-7018. PubMed ID: 21847071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activities of lactoferrin.
    van der Strate BW; Beljaars L; Molema G; Harmsen MC; Meijer DK
    Antiviral Res; 2001 Dec; 52(3):225-39. PubMed ID: 11675140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
    Ammendolia MG; Marchetti M; Superti F
    Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
    Chien YJ; Chen WJ; Hsu WL; Chiou SS
    Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin: an important host defence against microbial and viral attack.
    Valenti P; Antonini G
    Cell Mol Life Sci; 2005 Nov; 62(22):2576-87. PubMed ID: 16261253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
    Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
    Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate.
    Pietrantoni A; Fortuna C; Remoli ME; Ciufolini MG; Superti F
    Viruses; 2015 Jan; 7(2):480-95. PubMed ID: 25643293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate.
    Waarts BL; Aneke OJ; Smit JM; Kimata K; Bittman R; Meijer DK; Wilschut J
    Virology; 2005 Mar; 333(2):284-92. PubMed ID: 15721362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential lactoferrin activity against pathogenic viruses.
    Redwan EM; Uversky VN; El-Fakharany EM; Al-Mehdar H
    C R Biol; 2014 Oct; 337(10):581-95. PubMed ID: 25282173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial activity of lactoferrin: current status and perspectives.
    Orsi N
    Biometals; 2004 Jun; 17(3):189-96. PubMed ID: 15222464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
    Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
    J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.
    Zarzosa-Moreno D; Avalos-Gómez C; Ramírez-Texcalco LS; Torres-López E; Ramírez-Mondragón R; Hernández-Ramírez JO; Serrano-Luna J; de la Garza M
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33302377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin affects rhinovirus B-14 entry into H1-HeLa cells.
    Denani CB; Real-Hohn A; de Carvalho CAM; Gomes AMO; Gonçalves RB
    Arch Virol; 2021 Apr; 166(4):1203-1211. PubMed ID: 33606112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin functions: current status and perspectives.
    Valenti P; Berlutti F; Conte MP; Longhi C; Seganti L
    J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S127-9. PubMed ID: 15220678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peptides--a new strategy for combating viral infections].
    Kołodziej M; Joniec J; Bartoszcze M; Mirski T; Gryko R
    Przegl Epidemiol; 2011; 65(3):477-82. PubMed ID: 22184952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of lactoferrin towards naked viruses.
    Seganti L; Di Biase AM; Marchetti M; Pietrantoni A; Tinari A; Superti F
    Biometals; 2004 Jun; 17(3):295-9. PubMed ID: 15222481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
    Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
    Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of lactoferrin against canine herpesvirus.
    Tanaka T; Nakatani S; Xuan X; Kumura H; Igarashi I; Shimazaki Ki
    Antiviral Res; 2003 Nov; 60(3):193-9. PubMed ID: 14638395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin inhibits early steps of human BK polyomavirus infection.
    Longhi G; Pietropaolo V; Mischitelli M; Longhi C; Conte MP; Marchetti M; Tinari A; Valenti P; Degener AM; Seganti L; Superti F
    Antiviral Res; 2006 Nov; 72(2):145-52. PubMed ID: 16774792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide.
    Florian PE; Macovei A; Lazar C; Milac AL; Sokolowska I; Darie CC; Evans RW; Roseanu A; Branza-Nichita N
    J Med Virol; 2013 May; 85(5):780-8. PubMed ID: 23508903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.